Literature DB >> 14722919

Genetic characterization and structural analysis of VHL Spanish families to define genotype-phenotype correlations.

Sergio Ruiz-Llorente1, Jerónimo Bravo2, Arancha Cebrián1, Alberto Cascón1, Marina Pollan3, Dolores Tellería1, Rocío Letón1, Miguel Urioste4, Raquel Rodríguez-López4, Jose M de Campos5, María J Muñoz6, Carmen Lacambra7, Javier Benítez4, Mercedes Robledo1.   

Abstract

Von Hippel-Lindau (VHL) disease is a hereditary cancer syndrome caused by germline mutations in the VHL gene. This gene, located in the 3p25-26 chromosome, is a tumor suppressor gene associated with the inhibition of angiogenesis and apoptosis, cell cycle exit, fibronectin matrix assembly, and proteolysis. To define the molecular basis of VHL in a Spanish population, we studied 33 patients suspected of suffering familial or de novo VHL disease and two familial pheochromocytoma cases. Sequence analysis of the coding regions of the VHL gene revealed germline sequence variants in 68.7% (24 out of 35) of the patients, and four of them presented with undescribed germline alterations: g.5429-5430insG, p.Leu128Arg, p.Tyr175Cys, and p.Tyr175Asn. For the remaining 11 patients who showed negative for point mutations, we performed Southern blot analysis and detected gross rearrangements in eight cases (22.8% of the index cases). Our results support the relevance of VHL gene analysis in familial pheochromocytoma cases and also in those with no familial history. In order to investigate the relevance of different amino acid changes in the VHL phenotype, we also analyzed the genotype-phenotype correlations using structural analysis to assess protein stability and complexes. The association of clear cell renal carcinoma (CCRC) development with a relatively high loss of structural stability in pVHL missense-mutants was consistent. Structural stability data in the genotype-phenotype correlations therefore provides us with a better understanding of VHL clinical implications. It is also a suitable approach to the evaluation of unknown significance changes. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14722919     DOI: 10.1002/humu.10309

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  8 in total

1.  A meta-analysis of different von Hippel Lindau mutations: are they related to retinal capillary hemangioblastoma?

Authors:  Fatemeh Azimi; Ali Aghajani; Golnaz Khakpour; Samira Chaibakhsh
Journal:  Mol Genet Genomics       Date:  2022-08-25       Impact factor: 2.980

2.  Neuro-ophthalmology of von Hippel-Lindau.

Authors:  Eric W Fitz; Steven A Newman
Journal:  Curr Neurol Neurosci Rep       Date:  2004-09       Impact factor: 5.081

3.  VHL frameshift mutation as target of nonsense-mediated mRNA decay in Drosophila melanogaster and human HEK293 cell line.

Authors:  Lucia Micale; Lucia Anna Muscarella; Marco Marzulli; Bartolomeo Augello; Patrizia Tritto; Leonardo D'Agruma; Leopoldo Zelante; Gioacchino Palumbo; Giuseppe Merla
Journal:  J Biomed Biotechnol       Date:  2010-01-21

4.  Genotype-Phenotype Correlation in Patients With Germline Mutations of VHL, RET, SDHB, and SDHD Genes: Thai Experience.

Authors:  Chutintorn Sriphrapradang; Kitjapong Choopun; Atchara Tunteeratum; Thanyachai Sura
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2017-04-20

Review 5.  Pheochromocytomas and paragangliomas in von Hippel-Lindau disease: not a needle in a haystack.

Authors:  João Castro-Teles; Bernardo Sousa-Pinto; Sandra Rebelo; Duarte Pignatelli
Journal:  Endocr Connect       Date:  2021-10-27       Impact factor: 3.335

6.  Ser80Ile mutation and a concurrent Pro25Leu variant of the VHL gene in an extended Hungarian von Hippel-Lindau family.

Authors:  Attila Patocs; Peter Gergics; Katalin Balogh; Miklos Toth; Ferenc Fazakas; Istvan Liko; Karoly Racz
Journal:  BMC Med Genet       Date:  2008-04-16       Impact factor: 2.103

7.  An integrated computational approach can classify VHL missense mutations according to risk of clear cell renal carcinoma.

Authors:  Lucy Gossage; Douglas E V Pires; Álvaro Olivera-Nappa; Juan Asenjo; Mark Bycroft; Tom L Blundell; Tim Eisen
Journal:  Hum Mol Genet       Date:  2014-06-26       Impact factor: 6.150

8.  Bilateral Pheochromocytomas in a Patient with Y175C Von Hippel-Lindau Mutation.

Authors:  Olga Astapova; Anindita Biswas; Alessandra DiMauro; Jacob Moalem; Stephen R Hammes
Journal:  Case Rep Endocrinol       Date:  2018-07-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.